1. Home
  2. VRAX vs SOBR Comparison

VRAX vs SOBR Comparison

Compare VRAX & SOBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virax Biolabs Group Limited

VRAX

Virax Biolabs Group Limited

HOLD

Current Price

$0.66

Market Cap

2.8M

Sector

Health Care

ML Signal

HOLD

Logo SOBR Safe Inc.

SOBR

SOBR Safe Inc.

HOLD

Current Price

$1.49

Market Cap

2.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRAX
SOBR
Founded
2013
2004
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Newspapers/Magazines
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.8M
2.4M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
VRAX
SOBR
Price
$0.66
$1.49
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
14.7M
30.3K
Earning Date
01-01-0001
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,986.00
$364,164.00
Revenue This Year
$217,274.83
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
98.07
52 Week Low
$0.35
$1.27
52 Week High
$3.20
$57.00

Technical Indicators

Market Signals
Indicator
VRAX
SOBR
Relative Strength Index (RSI) 69.02 26.44
Support Level $0.39 $1.27
Resistance Level $0.43 $1.64
Average True Range (ATR) 0.06 0.20
MACD 0.02 -0.04
Stochastic Oscillator 55.35 14.19

Price Performance

Historical Comparison
VRAX
SOBR

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes (HSV-1) and Human Papillomavirus (HPV).

About SOBR SOBR Safe Inc.

Sobr Safe Inc provides non-invasive technology to quickly and humanely identify the presence of alcohol in individuals. Its technologies are integrated within robust and scalable data platform, producing statistical and measurable user and business data. It developed the scalable, patent-pending ea4 software platform for non-invasive alcohol detection and identity verification, a solution that has current and potential applications. It generates revenue through various combinations of software products and services which include the sale of cloud-based software solutions, detection and data collection hardware devices, and cloud-based data reporting and analysis services.

Share on Social Networks: